A young pregnant patient assumed abdominal pain and rectal bleeding was from her pregnancy. She was diagnosed with Stage IV ...
Colorectal cancer is now the leading cause of cancer deaths in people younger than 50. While routine screening is recommended ...
Lung cancer is now the leading cause of cancer deaths in the United States, claiming more lives than several other major ...
Modelling indicates that over a 20-year period, a national screening programme could detect around 9,000 lung cancers and potentially save more than 6,000 lives – an estimated 300 lives each year.
Private companies are capitalizing on this quest for information. Grail’s Galleri blood test screens for more than 50 different types of cancer from a single blood draw, while full-body MRI scans, ...
In 2026, an estimated 158,850 new cases of colorectal cancer (CRC) will be diagnosed, and 55,230 people will die from the ...
As a nonsmoker lung cancer hasn't been a concern of mine, but I recently heard it can affect people who have never smoked. If ...
The FDA granted zongertinib Breakthrough Therapy Designation for patients with HER2 (ERBB2)-mutant advanced NSCLC as an initial treatment. The FDA also awarded a Commissioner's National Priority ...
The nod allows Hernexeos (zongertinib) to be used as an initial treatment option for NSCLC with HER2-activating mutations in ...
This press release is not intended for UK mediaHERNEXEOS® (zongertinib tablets) approved based on an objective response rate of 76% (N=72) as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results